Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Figures and Graphics
Weller M  
Management of Gliomas: Relevance of Molecular Markers for Clinical Practice

European Association of NeuroOncology Magazine 2012; 2 (1): 6-10

PDF    Figures   


Figure
 
Molecular markers in glioma
Figure 1a-c: Molecular markers in glioma. A, 1p/19q co-deletion. Microsatellite-PCR-based analysis of allelic losses of 1p and 19q in an astrocytoma (WHO grade II) (A II) and an anaplastic oligodendroglioma (WHO grade III) (AO III). Losses of both markers are indicated by arrowheads in AO III, but not A II. B, MGMT promoter methylation. Methylation-specific PCR for unmethylated (U) and methylated (M) promoter sequences in 5 glioblastoma samples, including the glioblastoma cell line A172 as a positive control for methylated and peripheral blood cells as a control for unmethylated promoter sequences, as well as water as a negative control (empty). C, IDH mutation. Grade- II oligoastrocytoma, upper panels: HE staining, lower panels: IDH immunostaining, left panels: tumour centre, right panels: infiltration zone (Courtesy: Jörg Felsberg, Düsseldorf, Germany). Reprinted from [2].


Keywords: gliomaMarkerTumor
 
 
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum